Remodelamento da matriz extracelular da medula óssea em desnutrição protéica: possível relação da via de AKT com a expressão de fibronectina e metaloproteinases de matriz / Extracellular matriz remodeling of the bone marrow in protein malnutrition: possible relationship of AKT pathway with expression of fibronectin and matriz metalloproteínases

A desnutrição proteica (DP) pode ocasionar alterações na matriz extracelular (MEC) de diferentes órgãos e tecidos, inclusive o hematopoético, com comprometimento funcional. Estudos do nosso laboratório demonstraram, em modelo murino de DP, aumento da expressão proteica de fibronectina (FN) no estroma medular ósseo in vivo, principalmente na região subendosteal (local de fixação da célula tronco progenitora hemopoética). Já in vitro, no estroma medular ósseo, observou-se tanto o aumento quanto a diminuição de FN e a presença de suas isoformas. Essas alterações de FN parecem estar envolvidas com a hipoplasia da medula óssea (MO) em camundongos desnutridos. As modificações quantitativas de FN podem ser devidas: (i) à ação das metaloproteinases de matriz (MMP) responsáveis pela degradação das proteínas da MEC; (ii) aos inibidores de metaloproteinases (TIMP) que regulam a degradação da MEC; (iii) às alterações transcricionais, reguladas pela via de AKT/mTOR, que controla os splicing alternativos na FN, resultando em isoformas dessa proteína; (iv) a processos pós-transcricionais modulados por LC3, que aumenta a tradução do RNAm de FN. Assim, o objetivo deste estudo foi elucidar os mecanismos que alteram o turnover de FN no estroma medular ósseo em modelo murino de DP. Utilizamos camundongos, C57BL/6J machos, adultos, separados em dois grupos: controle e desnutrido, alimentados, ad libitum, com ração contendo 12% e 2% de proteína, respectivamente. Após cinco semanas de indução à desnutrição os camundongos foram eutanasiados, e coletado o material biológico. Avaliamos: o estado nutricional, o hematológico, a histologia da MO femoral bem como a determinação imunohistoquímica da FN, MMP-2 e MMP-9, determinação da expressão de FN e suas isoformas em células totais da MO, o estabelecimento do estroma medular ósseo in vitro, por 28 e 35 dias de cultivo. A partir das culturas foram avaliadas a expressão de RNAm de FN e suas isoformas, MMP-2, MMP-9, TIMP-1, TIMP-2, AKT, mTOR e LC3α e ß, quantificação de MMP-2, MMP-9, TIMP-1, TIMP-2,TNFα, TGFß e IL-1ß e determinação de LC3ß e proteínas da via de AKT/mTOR. Não observamos alterações na expressão do RNAm de FN e suas isoformas ex vivo e in vitro, mas um aumento da deposição de FN na MO.Também não observamos modificações na imunolocalização de MMP-2 e MMP-9 na MO e na atividade dessas proteínas no sobrenadante de culturas de células estromais in vitro, mas houve aumento da expressão do RNAm de MMP-9 em 28 dias de cultivo. Não detectamos alterações na expressão de RNAm e na concentração de TIMP-1 e TIMP-2 no sobrenadante das culturas. Houve redução significativa de TNFα e TGFß no sobrenadante das culturas de 28 dias. Observamos aumento da expressão do RNAm de mTOR em culturas de 28 dias e LC3α e LC3ß em 35 dias de células estromais. Encontramos menor fosforilação de PI3K, AKT, PTEN, mTOR e mTOR total e aumento de LC3ß em culturas de 28 dias, mas redução de LC3ß em 35 dias. Em função dos dados inferimos que a DP conduz a alterações da FN que não estão relacionadas à ação de MMPs e TIMPs e sim a modificações de LC3ß e da via de AKT/mTOR

Protein malnutrition (PM) can lead changes in extracellular matrix (ECM) from several organs and tissues, including hematopoietic, with functional impairments. Research from our laboratory demonstrated, in a murine model of protein malnutrition, increase in proteic expression of fibronectin (FN) in vivo bone marrow stroma, principally in subendosteal region (attachment site of hematopoietic stem/progenitor cell - HSPC). It was observed as both an increase and a decrease in the presence of FN and its isoforms in vitro bone marrow stroma. These FN changes seem to be related to bone marrow (BM) hypoplasia in malnourished mice. Quantitative FN changes may be due to: (i) action of matrix metalloproteinases (MMP) responsible for ECM proteins degradation; (ii) tissue inhibitors of metalloproteinases (TIMP) that regulate ECM degradation; (iii) transicional changes regulated by AKT/mTOR pathway, which controls alternative splicing in FN, resulting in isoforms from this protein; (iv) post-transcriptional processes modulated by LC3 that increases FN mRNA translation. Therefore, the aim of this study was to elucidade the mechanisms that changes the FN turnover in bone marrow stroma in a murine model of PM. C57BL/6J, adult and male mice were used and divided into two groups: control and malnourished, fed ad libitum with ration containing 12% and 2% of protein, respectively. After five weeks of induction malnutrition, mice were euthanized and the biological material was collected. We evaluated: nutritional and hematologic status, the femoral BM histology, immunohistochemistry determination of FN, MMP-2 and MMP-9, the FN and its isoforms expression determination in total BM cells, establishment of in vitro bone marrow stroma for 28 and 35 days of culture. From the cultures were evaluated FN mRNA expressions and its isoforms, MMP-2, MMP-9, TIMP-1, TIMP-2, AKT, mTOR, LC3α and ß, quantification of MMP-2, MMP-9, TIMP-1, TIMP-2,TNFα, TGFß and IL-1ß and determination of LC3ß and AKT/mTOR proteins. No changes were observed, ex vivo and in vitro, in the expression of FN mRNA and its isoforms, but there was a FN deposition increase in BM. We did not observe modifications in MMP-2 e MMP-9 immunolocalization in BM and in these proteins activity in the supernatant of in vitro stromal cell culture, but there was an increase in MMP-9 mRNA expression after 28 days of culture. We did not detect changes in mRNA and in TIMP-1 and TIMP-2 expressions in the supernatant of cultures. There was significant reduction of TNFα and TGFß in the cultures supernatant of 28 days. We observed an increase of mTOR RNAm in 28 days cultures and also LC3α and LC3ß in stromal cells with 35 days. We found lower phosphorylation of PI3K, AKT, PTEN, mTOR e total mTOR and an LC3ß increase in 28 days cultures, yet an LC3ß reduction in 35 days. According to the data we conclude that PM leads to FN changes that are not related to MMPs and TIMPs actions, but the LC3ß and AKT/mTOR pathway modifications

Expressão de MMP-2 e MMP-9 no endométrio de éguas saudáveis e portadoras de endometrite crônica / Expression of MMP-2 and MMP-9 in helth endometrium and in chronic endometritis of mares

Avaliaram-se, por método imunoistoquímico, a expressão e distribuição das metaloproteinases (MMP) 2 e 9 em amostras de endométrio hígido e de éguas portadoras de endometrite crônica. Foram utilizadas 60 biópsias endometriais. A MMP-2 foi observada na parede vascular, nas células estromais e no epitélio glandular, e a imunorreatividade mais intensa foi obtida nas células do epitélio glandular nas endometrites da categoria III e na parede vascular nos endométrios da categoria I. A marcação imunoistoquímica para MMP-9 mostrou-se difusa pelo endométrio e foi observada no epitélio luminal e glandular, na região da parede vascular, nas células estromais, endoteliais e do infiltrado inflamatório. Houve diminuição da marcação imunoistoquímica na região da parede vascular conforme aumentou o grau das lesões endometriais concomitante à diminuição da intensidade da reação. Não houve relação na expressão imunoistoquímica das metaloproteinases estudadas com o tipo de endometrite.

The expression and distribution of matrix metalloproteinases (MMP) 2 and 9 were evaluated in helth endometrium and in chronic endometrites of mares by means of immunohistochemistry method. Sixty endometrial biopsies were utilized. Expression of MMP-2 was observed in vascular wall, stromal cells, and glandular epithelium. More intense immune reaction was seen in glandular epithelial cells in category III endometritis and in vascular wall in category I endometrium. MMP-9 immune reaction was diffuse and was seen in luminal and glandular epithelium; vascular wall region; and stromal, endotelial, and inflammatory cells. There was a decreased of the immunohistochemical marking in vascular wall region as increased the degree of endometrial injury, as well as reducing the intensity of reaction in this compartment. There was no relation in immunohistochemistry expression of metalloproteinases with the type of endometritis.

Proteolytic activity of Cu(II) complex of 1-oxa-4,7,10-triazacyclododecane.

Proteolytic activity of the Cu(II) complex of 1-oxa-4,7,10-triazacyclododecane (oxacyclen) was compared with that of the Cu(II) complex of 1,4,7,10-tetraazacyclododecane by using albumin, gamma-globulin, and myoglobin as substrates. Values of kcat/Km were greater for Cu(II)oxacyclen by 40-80 times. The enhanced activity is attributed to the increased Lewis acidity of Cu(II) due to substitution of one nitrogen donor atom with oxygen.

Are adrenomedullin positive modulators novel matrix metalloproteinase inhibitors?

Las metaloproteasas de la matriz (MMPs) pertenecen a la familia de enzimasque contienen zinc y juegan un papel predominante en la degradación del tejidoconectivo. Por ello se consideran dianas terapéuticas para procesos de inflamacióny enfermedades malignas y degenerativas. Por otro lado, se ha demostrado recientementeque un miembro de esta familia, MMP-2, una colagenasa de tipo IV tambiénconocida como gelatinasa A, es capaz de degradar un péptido angiogénico denominadoadrenomedulina (AM) (1). AM es una hormona peptídica que desarrolla unpapel importante en diversas patologías como diabetes, hipertensión y cáncer. Seha identificado mediante un cribado de alto rendimiento (HTS) de la colección decompuestos del Instituto Nacional del Cáncer (NCI), una serie de moduladores coninteresante actividad hipotensora (2). El mecanismo de acción de estos moduladoreses desconocido y nosotros proponemos que pueden afectar a la biodisponibilidadde la AM en el torrente sanguíneo por medio de la inhibición de la actividad dela MMP-2. En este trabajo presentamos un estudio teórico que hace uso de técnicascomo mecánica molecular, docking y Cribado Virtual con el objetivo de demostraresa hipótesis. A continuación del estudio computacional se llevó a cabo la evaluaciónbiológica de algunos compuestos, permitiéndonos proponer un nuevo tipo deZBG que puede ser interesante para el diseño de nuevos inhibidores de MMPS, coninterés como agentes anticancerosos y antiangiogénicos

Matrix metalloproteinases (MMPs), are a family of structurally related zinccontaining enzymes that play a major role in the breakdown of connective tissueand therefore, are targets for therapeutic inhibitors in many inflammatory,malignant, and degenerative diseases. On the other hand, it has been recentlydemonstrated that one of these enzymes, MMP-2, a type IV collagenase, termedgelatinase A, cleaves the angiogenic peptide adrenomedullin (AM) (1). AM is apeptide hormone that plays a critical role in several diseases such as diabetes,hypertension and cancer. In a High Throughput Screening (HTS) carried out at theNational Cancer Institute (NCI), a series of AM modulators were identified, with aninteresting hypotensive activity (2). In order to shed light into the mechanism ofaction of these interesting compounds, we have hypothesized that they may be affecting the biodisponibility of AM in the blood stream by inhibiting the MMP-2protease activity. In the present work, we present a theoretical study, making useof molecular mechanics, docking and virtual screening techniques, with the aim ofdemonstrating this hypothesis. Biological evaluation of MMP-2 inhibition by someselected compounds, followed the computational work, leading us to propose astructurally new type of MMP-2 inhibitors, with possible interest as anticancer andantiangiogenic agents

Degradation of myoglobin by polymeric artificial metalloproteases containing catalytic modules with various catalytic group densities: site selectivity in peptide bond cleavage.

Mononuclear, dinuclear, and tetranuclear artificial metalloproteases were prepared by attaching respective catalytic modules containing the Cu(II) complex of cyclen (Cu(II)Cyc) to a derivative of cross-linked polystyrene. The polymeric artificial metalloproteases effectively cleaved peptide bonds of myoglobin (Mb) by hydrolysis. The proteolytic activity increased considerably as the catalytic group density was raised: the ratio of k(cat)/K(m) was 1:13:100 for the mono-, di-, and tetranuclear catalysts. In the degradation of Mb by the dinuclear catalyst, two pairs of intermediate proteins accumulated. One of the two initial cleavage sites leading to the formation of the protein fragments is identified as Gln(91)-Ser(92) and the other is suggested as Ala(94)-Thr(95). On the basis of a molecular modeling study by using the X-ray crystallographic structure of Mb, the site-selectivity is attributed to anchorage of one Cu(II)Cyc unit of the catalytic module to a heme carboxylate of Mb. The high site selectivity for the initial cleavage of a protein substrate and mechanistic analysis of the catalytic action are unprecedented for polymeric artificial enzymes.

Synthetic artificial peptidases and nucleases using macromolecular catalytic systems.

Effective artificial enzymes have been designed by adopting macromolecular systems for catalyst-substrate complexes. Artificial active sites comprising two or more organic functional groups were built on macromolecular backbones, leading to several types of organic artificial proteases. The activity of metal centers for peptide or DNA hydrolysis was greatly enhanced by attachment to polystyrene, leading to artificial metallopeptidases with substrate selectivity as well as artificial metallonucleases with high catalytic activity for double stranded DNA. A small artificial protease selective for a macromolecular target protein was synthesized. Target-specific artificial proteases can be used as protein-cleaving catalytic drugs.